Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.94
+$0.03 (+3.30%)
After-hours:
Sep 21, 2026, 7:59 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 36.31M | 34.87M | 24.09M | 4.35M | 228.43K | 71.41K |
Cost of Revenue | 24.38M | 24.2M | 15.75M | 2.65M | 117.83K | 25.85K |
Gross Profit | 11.92M | 10.67M | 8.34M | 1.7M | 110.6K | 45.56K |
Operating Income | -4.48M | -5.81M | -4.79M | -8.67M | -2.44M | -576.87K |
Interest Income | 280.9K | 496K | 811.97K | 518.65K | n/a | n/a |
Pretax Income | -5.95M | -5.37M | -4.11M | -26.51M | -12.44M | -2.78M |
Net Income | -5.98M | -5.13M | -4.51M | -26.74M | -12.44M | -2.78M |
Selling & General & Admin | 19.63M | 14.94M | 10.83M | 9.48M | 1.87M | 606.64K |
Research & Development | 604.31K | 933.9K | 1.86M | 811.86K | 672.21K | 1.73K |
Other Expenses | -3.83M | 610.53K | 438.88K | 80.4K | 12.74K | 14.07K |
Operating Expenses | 16.4M | 16.48M | 13.12M | 10.37M | 2.55M | 622.44K |
Interest Expense | n/a | 8.77K | 137.31K | 39.41K | 328.82K | 168.11K |
Selling & Marketing Expenses | 1.14M | 940.28K | 734.25K | 578.09K | 1.22M | n/a |
Cost & Expenses | 40.78M | 40.69M | 28.88M | 13.02M | 2.67M | 648.28K |
Income Tax Expense | 21.61K | -234.86K | 395.17K | 233.3K | n/a | n/a |
Shares Outstanding (Basic) | 415.71K | 70.18K | 1.22K | 759 | 131 | 87 |
Shares Outstanding (Diluted) | 415.71K | 70.18K | 1.22K | 759 | 131 | 87 |
EPS (Basic) | -14.40 | -73.20 | -3.51K | -35.24K | -97.74K | -32.15K |
EPS (Diluted) | -14.40 | -73.20 | -3.51K | -35.24K | -95.2K | -32.15K |
EBITDA | -5.62M | -5.14M | -3.82M | -26.45M | -12.09M | -2.6M |
EBIT | -5.95M | -5.36M | -3.97M | -26.47M | -12.11M | -2.62M |
Depreciation & Amortization | 332.07K | 223.53K | 149.15K | 25.16K | 12.74K | 14.07K |
Add to Watchlist
Select watchlists to add or remove SBFM